Dr. James Suliburk's research program at Ben Taub Hospital offers opportunities in translational science, clinical outcomes and technology development and innovation. Research interests include clinical outcomes in endocrine surgery in underserved and minority populations, outcomes in acute care and trauma surgery and application of mobile technology to improve peri-operative surgical care and communication. The research comes from the establishment of a comprehensive and multidisciplinary treatment of endocrine surgical program at Ben Taub Hospital in addition to the creation and standardization hemorrhagic shock resuscitation pathways for severely injured trauma patients.
Translational research opportunities include development of novel molecular markers to predict outcome in endocrine surgical disease (thyroid cancer, hyperthyroidism, hyperparathyroidism, and adrenal tumors) as well as metabolic markers of the endocrine response in severely injured major trauma patients. Clinical research includes outcomes analysis of access to care for underserved populations undergoing endocrine surgery along with developing novel percutaneous surgical approaches to treat thyroid, parathyroid and adrenal disease and ongoing refinement of hemorrhagic shock resuscitation strategies to improve survival in our trauma patients.
Finally and perhaps most exciting is work recently begun in technology and innovation. Mobile technology has become an ever-present part of daily life and I have now begun to study and apply methods of utilizing automated mobile technology to improve communication with patients for detection of impending complications and to supplement peri-operative care for surgical patients.